JP2010513228A - プロテインａ選択性を有する抗体 - Google Patents

プロテインａ選択性を有する抗体 Download PDF

Info

Publication number
JP2010513228A
JP2010513228A JP2009538452A JP2009538452A JP2010513228A JP 2010513228 A JP2010513228 A JP 2010513228A JP 2009538452 A JP2009538452 A JP 2009538452A JP 2009538452 A JP2009538452 A JP 2009538452A JP 2010513228 A JP2010513228 A JP 2010513228A
Authority
JP
Japan
Prior art keywords
antibody
antigen
cell line
monoclonal antibody
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009538452A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010513228A5 (https=
Inventor
エー． マッチ，パトリック
エス． レイフ−ウェンナー，マーラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of JP2010513228A publication Critical patent/JP2010513228A/ja
Publication of JP2010513228A5 publication Critical patent/JP2010513228A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2009538452A 2006-11-22 2007-11-15 プロテインａ選択性を有する抗体 Withdrawn JP2010513228A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/562,747 US20100047252A1 (en) 2006-11-22 2006-11-22 Antibody with protein a selectivity
PCT/US2007/084739 WO2008143697A2 (en) 2006-11-22 2007-11-15 Antibody with protein a selectivity

Publications (2)

Publication Number Publication Date
JP2010513228A true JP2010513228A (ja) 2010-04-30
JP2010513228A5 JP2010513228A5 (https=) 2011-01-13

Family

ID=39811884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009538452A Withdrawn JP2010513228A (ja) 2006-11-22 2007-11-15 プロテインａ選択性を有する抗体

Country Status (4)

Country Link
US (1) US20100047252A1 (https=)
EP (1) EP2084186A2 (https=)
JP (1) JP2010513228A (https=)
WO (1) WO2008143697A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100062418A1 (en) * 2006-11-22 2010-03-11 Mach Patrick A Inactivated and dried biological preparations
US20100099115A1 (en) 2006-11-22 2010-04-22 Mach Patrick A Systems and methods for preparing and analyzing samples
EP2137533A2 (en) * 2007-04-19 2009-12-30 3M Innovative Properties Company Uses of water-dispersible silica nanoparticles for attaching biomolecules
WO2008131063A1 (en) * 2007-04-19 2008-10-30 3M Innovative Properties Company Methods of use of solid support material for binding biomolecules
CN101918842A (zh) * 2007-11-20 2010-12-15 3M创新有限公司 利用含二乙炔的聚合物传感器分析细菌样品的方法
EP2250503A2 (en) * 2008-02-20 2010-11-17 3M Innovative Properties Company Methods of analyzing samples for bacteria using whole cell capture and atp analysis
ES2784957T3 (es) 2009-04-03 2020-10-02 Univ Chicago Composiciones y métodos relacionados con variantes de la proteína A (SPA)
JP6002128B2 (ja) 2010-07-02 2016-10-05 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ プロテインＡ（ＳｐＡ）変種に関連する組成物および方法
BR112014003315A2 (pt) 2011-08-15 2017-03-01 Univ Chicago composições e métodos relacionados a anticorpos para a proteína a estafilocócica
US9988439B2 (en) 2011-12-23 2018-06-05 Nicholas B. Lydon Immunoglobulins and variants directed against pathogenic microbes
WO2013096948A1 (en) 2011-12-23 2013-06-27 Lydon Nicholas B Immunoglobulins and variants directed against pathogenic microbes
US10738121B2 (en) 2015-02-27 2020-08-11 The General Hospital Corporation Therapeutic use of integrin-binding antibodies
MX2021013833A (es) 2019-05-14 2022-03-17 Univ Chicago Metodos y composiciones que comprenden variantes de la proteina a de estafilococos (spa).
WO2021051136A1 (en) 2019-09-13 2021-03-18 The University Of Chicago Methods and compositions for treating staphylococcal infections
CN118580347B (zh) * 2024-05-13 2025-02-07 重庆原伦生物科技有限公司 一种抗金黄色葡萄球菌蛋白a的单克隆抗体及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4741900A (en) * 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US6994855B1 (en) * 1994-08-22 2006-02-07 The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
US6008341A (en) * 1994-08-22 1999-12-28 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
US5594116A (en) * 1995-11-08 1997-01-14 Promega Corporation Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay
FR2746398B1 (fr) * 1996-03-21 1998-04-30 Bio Merieux Anticorps specifique de staphylococcus aureaus, et utilisations
JP4424984B2 (ja) * 2001-06-15 2010-03-03 インヒビテックス インコーポレーテッド コアグラーゼ陰性ブドウ球菌および黄色ブドウ球菌由来の表面蛋白質を認識する、交差反応性モノクローナルおよびポリクローナル抗体
WO2003059935A2 (en) * 2001-12-21 2003-07-24 Immunex Corporation Methods for purifying protein
AU2003284643A1 (en) * 2002-11-22 2004-06-18 Daiichi Pure Chemicals Co., Ltd. Method of examining staphylococcus aureus
WO2008064232A2 (en) * 2006-11-22 2008-05-29 3M Innovative Properties Company Fluidic antibody-containing devices and methods

Also Published As

Publication number Publication date
EP2084186A2 (en) 2009-08-05
WO2008143697A2 (en) 2008-11-27
WO2008143697A3 (en) 2009-03-05
US20100047252A1 (en) 2010-02-25

Similar Documents

Publication Publication Date Title
JP2010513228A (ja) プロテインａ選択性を有する抗体
JP2010509937A (ja) プロテインａ選択性を有する抗体
CN112250763B (zh) 靶向SARS-CoV-2冠状病毒的抗体及其诊断和检测用途
CN110944666B (zh) 杂交瘤克隆、vsig-4的单克隆抗体，以及制备和使用的方法
TWI655209B (zh) 結合人類計畫性死亡（ｐｒｏｇｒａｍｍｅｄ ｄｅａｔｈ）配位子１（ｐｄ－ｌ１）之抗體
JP2011512817A (ja) クロストリジウム・ディフィシル胞子に対する抗体及びその使用
US8735554B2 (en) Reagents, methods, and systems for detecting methicillin-resistant Staphylococcus
JP2014534169A (ja) Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓエピトープ結合部位を形成するペプチドまたはペプチドの配置
Sunwoo et al. Quantitative and sensitive detection of the SARS-CoV spike protein using bispecific monoclonal antibody-based enzyme-linked immunoassay
US20220119546A1 (en) Plectin-1 binding antibodies and uses thereof
US11866487B2 (en) Filamin A binding proteins and uses thereof
CN119306826A (zh) 抗白介素-6抗体、检测白介素-6的试剂和试剂盒
US20070298034A9 (en) Sulfotyrosine specific antibodies and uses therefor
US10981979B2 (en) Human monoclonal antibodies to Staphylococcus aureus lukab toxin
US20230408517A1 (en) Anti-severe acute respiratory syndrome coronavirus antibodies
CN120225680A (zh) 针对外被体蛋白复合物亚基β2的抗体
CN119080929A (zh) 抗白介素6抗体、检测白介素6的试剂和试剂盒
CN119285761B (zh) 抗幽门螺杆菌抗体、检测幽门螺杆菌的试剂和试剂盒
CN119306828B (zh) 抗降钙素原抗体、检测降钙素原的试剂和试剂盒
CN119306833B (zh) 抗降钙素原抗体、检测降钙素原的试剂和试剂盒
JP7778307B2 (ja) ウェルシュ菌エンテロトキシンの検出方法
CN121045369A (zh) 新冠病毒n蛋白的特异性抗体及其应用
CN119285763A (zh) 抗铁蛋白抗体、检测铁蛋白的试剂和试剂盒
US20220153818A1 (en) Antibody molecules and uses thereof
CN120424209A (zh) 一种抗降钙素原的抗体及其应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101115

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101115

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20110406